David M. Lowe

10.2k total citations · 2 hit papers
110 papers, 6.4k citations indexed

About

David M. Lowe is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, David M. Lowe has authored 110 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 28 papers in Epidemiology and 27 papers in Immunology. Recurrent topics in David M. Lowe's work include Immunodeficiency and Autoimmune Disorders (19 papers), Marine Bivalve and Aquaculture Studies (17 papers) and Environmental Toxicology and Ecotoxicology (16 papers). David M. Lowe is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (19 papers), Marine Bivalve and Aquaculture Studies (17 papers) and Environmental Toxicology and Ecotoxicology (16 papers). David M. Lowe collaborates with scholars based in United Kingdom, Germany and South Africa. David M. Lowe's co-authors include Tamara S. Galloway, Awantha Dissanayake, Mark A. Oakley Browne, Richard C. Thompson, Michael N. Moore, Angela Köehler, A. Viarengo, B. L. Bayne, Claudia Bolognesi and Elena Fabbri and has published in prestigious journals such as Journal of Clinical Investigation, Environmental Science & Technology and PLoS ONE.

In The Last Decade

David M. Lowe

103 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ingested Microscopic Plastic Translocates to the Circulatory System of the Mussel, Mytilus edulis (L.)

2008 1.8k citations David M. Lowe et al. profile →
The use of biomarkers in biomonitoring: A 2-tier approach assessing the level of pollutant-induced stress syndrome in sentinel organisms

2007 579 citations David M. Lowe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Lowe United Kingdom	37	2.4k	2.0k	1.1k	1.1k	930	110	6.4k
Stuart L. Simpson Australia	51	3.7k 1.5×	3.3k 1.6×	541 0.5×	229 0.2×	1.2k 1.2×	230	9.6k
Hiroshi Sakugawa Japan	42	801 0.3×	1.2k 0.6×	438 0.4×	336 0.3×	406 0.4×	221	7.6k
Werner Manz Germany	39	3.1k 1.3×	1.7k 0.8×	163 0.1×	529 0.5×	3.1k 3.3×	75	7.8k
Satoru Suzuki Japan	37	3.0k 1.2×	660 0.3×	205 0.2×	200 0.2×	1.1k 1.2×	211	6.1k
Alexandre Soares Rosado Brazil	50	1.6k 0.7×	440 0.2×	254 0.2×	212 0.2×	2.9k 3.1×	194	7.4k
Letizia Marsili Italy	37	2.0k 0.8×	2.0k 1.0×	351 0.3×	1.0k 0.9×	1.2k 1.3×	177	4.8k
Hui Zhang China	35	515 0.2×	445 0.2×	559 0.5×	244 0.2×	1.1k 1.2×	319	5.7k
Massimo Milan Italy	29	1.6k 0.6×	837 0.4×	501 0.4×	597 0.5×	446 0.5×	110	3.5k
Richard Devereux United States	27	2.1k 0.9×	664 0.3×	286 0.2×	230 0.2×	3.1k 3.4×	56	6.4k
Dapeng Li China	44	785 0.3×	714 0.4×	219 0.2×	351 0.3×	989 1.1×	304	7.2k

Countries citing papers authored by David M. Lowe

Since Specialization

Citations

This map shows the geographic impact of David M. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Lowe more than expected).

Fields of papers citing papers by David M. Lowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Lowe. The network helps show where David M. Lowe may publish in the future.

Co-authorship network of co-authors of David M. Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Lowe. A scholar is included among the top collaborators of David M. Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Lowe. David M. Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Owens, Katherine, Joseph F. Standing, David M. Lowe, et al.. (2025). Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2. Journal of Clinical Investigation. 135(21).

Campos, Luiza C., George Meligonis, David M. Lowe, et al.. (2025). Skin Manifestations in Adults With Chronic Granulomatous Disease in the United Kingdom. The Journal of Allergy and Clinical Immunology In Practice. 13(8). 2151–2161.e7.

Fernando, Raymond, David M. Lowe, Ashutosh Wechalekar, et al.. (2024). Renal Transplant Outcomes in Plasma Cell Dyscrasias and AL Amyloidosis after Treatment with Daratumumab. Journal of Clinical Medicine. 13(14). 4109–4109.

Maimaris, Jesmeen, et al.. (2023). Immunoglobulin Replacement Therapy During COVID-19 Pandemic: Practical and Psychological Impact in Patients with Antibody Deficiency. Journal of Clinical Immunology. 43(7). 1519–1525. 1 indexed citations

Hall, Andrew, Niall Burke, Siobhan O. Burns, et al.. (2023). Common variable immunodeficiency disorder (CVID)-related liver disease: assessment of the main histological aspects using novel semiquantitative scoring systems, image analysis and correlation with clinical parameters of liver stiffness and portal hypertension. Journal of Clinical Pathology. 77(10). 709–716. 5 indexed citations

Brown, James, Marc Lipman, David M. Lowe, et al.. (2023). Impact of prophylactic and ‘rescue pack’ antibiotics on the airway microbiome in chronic lung disease. BMJ Open Respiratory Research. 10(1). e001335–e001335. 10 indexed citations

Nunes, Alexandra, Mónica Oleastro, Nadia Liassine, et al.. (2023). Recurrent Campylobacter jejuni Infections with In Vivo Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants. Microbiology Spectrum. 11(4). e0107023–e0107023. 8 indexed citations

Guerra‐Assunção, José Afonso, Angie Lackenby, Sarita Workman, et al.. (2023). Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients. Journal of Clinical Immunology. 43(6). 1083–1092. 15 indexed citations

Halliday, Neil, Niall Burke, Andrew Hall, et al.. (2023). Common variable immunodeficiency disorder-related liver disease is common and results in portal hypertension and an increased risk of death. Hepatology Communications. 8(1). 4 indexed citations

10.

Reuschl, Ann‐Kathrin, Tianyi Chen, Mervyn Singer, et al.. (2022). Executable network of SARS-CoV-2-host interaction predicts drug combination treatments. npj Digital Medicine. 5(1). 18–18. 10 indexed citations

11.

Agyeman, Akosua Adom, Tao You, Phylinda L. S. Chan, et al.. (2022). Comparative assessment of viral dynamic models for SARS‐CoV‐2 for pharmacodynamic assessment in early treatment trials. British Journal of Clinical Pharmacology. 88(12). 5428–5433. 3 indexed citations

12.

Lowe, David M., et al.. (2022). Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal change in lung function in a single-centre cohort. ERJ Open Research. 8(4). 24–2022. 4 indexed citations

13.

Moreira, Fernando, Samreen Ijaz, Andrew Symes, et al.. (2018). Absence of Persistent Hepatitis E Virus Infection in Antibody-Deficient Patients Is Associated With Transfer of Antigen-Neutralizing Antibodies From Immunoglobulin Products. The Journal of Infectious Diseases. 219(2). 245–253. 7 indexed citations

14.

Lake, Marilyn, Lyn Ambrose, Marc Lipman, & David M. Lowe. (2016). ‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Medicine. 14(1). 54–54. 87 indexed citations

15.

Lowe, David M., Nonzwakazi Bangani, René Goliath, et al.. (2015). Effect of Antiretroviral Therapy on HIV-mediated Impairment of the Neutrophil Antimycobacterial Response. Annals of the American Thoracic Society. 12(11). 1627–1637. 17 indexed citations

16.

Lowe, David M., Nonzwakazi Bangani, Dirk Lang, et al.. (2013). A novel assay of antimycobacterial activity and phagocytosis by human neutrophils. Tuberculosis. 93(2). 167–178. 9 indexed citations

17.

Yawn, Barbara P., Peter C. Wollan, Susan Bertram, et al.. (2007). Asthma Treatment in a Population-Based Cohort: Putting Step-Up and Step-Down Treatment Changes in Context. Mayo Clinic Proceedings. 82(4). 414–421. 26 indexed citations

18.

Hardiman, Paul, et al.. (1996). Measurement of interleukin-1 alpha and interleukin-6 in pregnancy-associated tissues. Reproduction Fertility and Development. 8(7). 1069–1073. 20 indexed citations

19.

Lowe, David M., et al.. (1990). 7TH NERVE PALSY AFTER EXTRADURAL BLOOD PATCH. British Journal of Anaesthesia. 65(5). 721–722. 18 indexed citations

20.

Moore, M. N., D.R. Livingstone, J. Widdows, David M. Lowe, & R.K. Pipe. (1987). Molecular, cellular and physiological effects of oil-derived hydrocarbons on molluscs and their use in impact assessment. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 316(1181). 603–623. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact